4//SEC Filing
Lang James Paul 4
Accession 0001628280-25-013918
CIK 0001448431other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:40 PM ET
Size
5.4 KB
Accession
0001628280-25-013918
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Lang James Paul
Director
Transactions
- Purchase
Common Stock
2025-03-14$7.60/sh+321,408$2,443,761→ 389,452 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.18 through $7.80. The reporting person undertakes to provide to the Issuer., any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001703090
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:40 PM ET
- Size
- 5.4 KB